Insider Selling: CFO Kevin Green Sells 82,657 Shares of Cerus Corp (CERS)
Institutional Investors Have a Lot Riding on Cerus Corporation (NASDAQ:CERS) With 65% Ownership
ZoomInfo Reports Weak Results, Joins Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
MercadoLibre Posts Upbeat Results, Joins Integral Ad Science, Willdan Group, Fresh Del Monte Produce And Other Big Stocks Moving Higher On Friday
Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Takeda Pharmaceutical Co (OtherTKPHF), Cerus (CERS) and Ultragenyx Pharmaceutical (RARE)
Stifel Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $6
TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5
Cerus Corporation: A Strong Buy on Robust Revenue Growth and Market Expansion
Express News | Cerus Shares Are Trading Higher After the Company Reported Better-than-expected Q2 EPS Results and Raised Its FY24 Product Revenue Guidance Above Estimates
Express News | Cerus Reiterates FY24 IFC Revenue Guidance Of $8M - $10M
Express News | Cerus Increases FY24 Product Revenue Guidance Range From $172M-$175M To $175M-$178M
Cerus | 10-Q: Q2 2024 Earnings Report
Express News | Cerus Corp - Increasing Full-Year 2024 Product Revenue Guidance Range From $172-175 Mln to $175-178 Mln
Cerus Remains Committed to Adj EBITDA Breakeven for FY24
Cerus Continues to Expect Future Improvements to GAAP Loss for FY24
Cerus GAAP EPS of -$0.03 Beats by $0.01, Revenue of $50.5M Beats by $7.99M
Cerus: Q2 Earnings Snapshot
Earnings Flash (CERS) CERUS CORPORATION Reports Q2 Revenue $50.5M, Vs. Street Est of $42.5M
Express News | Cerus Q2 Operating Expenses USD 33.9 Million